Successful treatment with subcutaneous ofatumumab in an adolescent patient with refractory myelin oligodendrocyte glycoprotein-immunoglobulin G-associated disease (MOGAD)

Preventing relapse of myelin oligodendrocyte glycoprotein-immunoglobulin G-associated disease (MOGAD) with steroids and immunosuppressants is sometimes difficult. There is no standard treatment for refractory cases. We present the case of a 17-year-old female patient with longitudinally extensive my...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Ngā kaituhi matua:	Satomi Hiya, Hajime Yoshimura, Michi Kawamoto
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	Elsevier 2023-06-01
Rangatū:	eNeurologicalSci
Ngā marau:	Myelin oligodendrocyte glycoprotein-immunoglobulin G-associated disease (MOGAD) Adolescent Neuromyelitis optica spectrum disorder (NMOSD) Multiple sclerosis (MS) Ofatumumab
Urunga tuihono:	http://www.sciencedirect.com/science/article/pii/S2405650223000199
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!